and epitope-optimized antibody–drug conjugates, to bispecific antibodies and chimeric antigen receptors for cell-based therapies. RubrYc’s collaboration model includes options for co-discovery ...

It is possible to substantially enhance these antibodies’ therapeutic potential via humanization, effectively reducing ...

Kumamoto University researchers have identified a powerful antibody that can neutralize a wide range of SARS-CoV-2 variants, ...

AK0610 is engineered from an antibody isolated from a recovered infant and targets the pre-fusion F protein of RSV.

OmniAb, Inc. (NASDAQ: OABI) today announced that two presentations featuring the Company's technologies were delivered at the 2024 Antibody Engineering & Therapeutics Conference (AETC) underway in San ...